.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Novartis
Cipla
Boehringer Ingelheim
Fuji
Colorcon
Mallinckrodt
Johnson and Johnson
Teva

Generated: July 25, 2017

DrugPatentWatch Database Preview

CYTOXAN Drug Profile

« Back to Dashboard

Which patents cover Cytoxan, and when can generic versions of Cytoxan launch?

Cytoxan is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in CYTOXAN is cyclophosphamide. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.

Summary for Tradename: CYTOXAN

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list116
Clinical Trials: see list147
Patent Applications: see list9,798
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CYTOXAN at DailyMed

Pharmacology for Tradename: CYTOXAN

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
CYTOXAN
cyclophosphamide
TABLET;ORAL012141-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-005Aug 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN
cyclophosphamide
INJECTABLE;INJECTION012142-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-009Dec 10, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN
cyclophosphamide
TABLET;ORAL012141-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cipla
Moodys
Chubb
UBS
McKinsey
Cerilliant
Farmers Insurance
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot